BOULDER, Colo., May 7, 2019 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today reported results for its third quarter of fiscal 2019 and provided an update on the progress of its key commercial products and clinical development programs. "U.S. demand for BRAFTOVI + MEKTOVI for...